U.S. Diagnostic Enzymes Market Size & Outlook, 2026-2033

Name: U.S. Diagnostic Enzymes Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The diagnostic enzymes market in the United States is expected to reach a projected revenue of US$ 3,575.4 million by 2033. A compound annual growth rate of 7.1% is expected of the United States diagnostic enzymes market from 2026 to 2033.

Clinical Diagnostics
- Reagents & Assays
  - Diagnostic Enzymes Market Outlook

U.S. diagnostic enzymes type outlook (Revenue, USD million, 2021-2033)
- UNG
- RNase inhibitor
- PCR Master Mix
- Acid phosphatase
- Alanine aminotransferase
- Angiotensin converting enzyme
- Gamma glutamyl transferase
- Renin
- Taq polymerase
- MMLV RT
- T7 RNA polymerase
- Cas9 enzyme
- Alkaline phosphatase
- Lactate dehydrogenase
- Glutamate oxidase
- HIV RT
- Hot start Taq pol
- Lyophilised Polymerase
- Glucose oxidase/glucose dehydrogenase
- Others
- Bst polymerase (LAMP enzyme)
- Amylase
- Aspartate aminotransferase
- Cholinesterase
- Creatinine kinase
- Urease
- Lactate oxidase
- Horseradish peroxidase
U.S. diagnostic enzymes application outlook (Revenue, USD million, 2021-2033)
- Diabetes
- Oncology
- Infectious Diseases
- Autoimmune Diseases
- Others
- Cardiology
- Nephrology
U.S. diagnostic enzymes product outlook (Revenue, USD million, 2021-2033)
- Molecular Enzymes
- Clinical Enzymes
U.S. diagnostic enzymes end use outlook (Revenue, USD million, 2021-2033)
- Hospitals
- Clinical Laboratories
- Other End Users

U.S. Diagnostic Enzymes Market Size & Outlook, 2026-2033

Data Tree

Sign up - it's easy, and free!